Zacks Investment Research on MSN

DXCM receives FDA clearance for Stelo OTC CGM system for children

DexCom DXCM received FDA clearance for its Stelo Glucose Biosensor System for use in children aged two years and older who do ...
CNET

The FDA Just Cleared the First OTC Continuous Glucose Monitor for Children

Stelo can now be marketed for children 2 years of age and older who do not use insulin.

DexCom Expands Beyond CGMs With CONNECT Results AI Apps And Nutrisense Deal

DexCom (NasdaqGS:DXCM) reported new clinical data from its CONNECT trial on the Dexcom G7 continuous glucose monitoring system in adults with Type 2 diabetes not using insulin. The company introduced ...
Drug Delivery Business

Dexcom to acquire wellness tracking company Nutrisense, launch enhanced Stelo app

Dexcom (Nasdaq:DXCM) announced today that entered into an agreement to acquire Nutrisense and shared plans for upgrades to ...
NBC Chicago

Dexcom launches first over-the-counter continuous glucose monitor. Here's what it's like

Glucose is a type of sugar people receive from food, and it's the body's main source of energy. Continuous glucose monitors, or CGMs, are small sensors that poke through the skin to measure glucose ...
Business Wire

Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...

Dexcom buys Nutrisense; Insulet rolls out patch pump update

In the lead-up to the American Diabetes Association’s Scientific Sessions, Dexcom announced an acquisition and Insulet rolled ...

Trying an OTC CGM for Diabetes? Compare Stelo, Lingo and Levels Before Buying One

CGMs can help people avoid serious diabetes complications, save money through better management and adjust behavior based on feedback.
Business Wire

Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users ...